Breast Cancer Screening: Why Starting Mammograms at 40 Could Save More Lives
When should women start getting mammograms, and how often should they have them? These are important questions because...
A New Option for Advanced Breast Cancer: Understanding Sacituzumab Govitecan
A new 2024 study in Frontiers in Oncology looked at sacituzumab govitecan, a targeted therapy for triple-negative breast cancer (TNBC)—a fast-growing cancer with fewer treatment options. Already FDA-approved, this drug continues to show promising results, even in real-world settings, for women who’ve run out of standard treatment options.
Reported by
Reviewed by
You May Also Like
How Well Does Orforglipron (Foundayo) Actually Work?
How well does Orforglipron, also called Foundayo, actually work? To understand how well it works, researchers ran a large clinical trial with over 3,100 adults with obesity.
What Causes a Stroke?
A stroke happens when blood flow to part of the brain is blocked or when a blood vessel in the brain bursts. Without oxygen-rich blood, brain cells begin to die within minutes.